Cargando…
Therapeutic targeting of cancer cell cycle using proteasome inhibitors
Proteasomes are multicatalytic protease complexes in the cell, involved in the non-lysosomal recycling of intra-cellular proteins. Proteasomes play a critical role in regulation of cell division in both normal as well as cancer cells. In cancer cells this homeostatic function is deregulated leading...
Autores principales: | Rastogi, Namrata, Mishra, Durga Prasad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584802/ https://www.ncbi.nlm.nih.gov/pubmed/23268747 http://dx.doi.org/10.1186/1747-1028-7-26 |
Ejemplares similares
-
Proteasome inhibition mediates p53 reactivation and anti-cancer activity of 6-Gingerol in cervical cancer cells
por: Rastogi, Namrata, et al.
Publicado: (2015) -
Targeting the Ubiquitin-Proteasome System for Cancer Therapeutics by Small-Molecule Inhibitors
por: LaPlante, Gabriel, et al.
Publicado: (2021) -
Inhibition of STAT3, FAK and Src mediated signaling reduces cancer stem cell load, tumorigenic potential and metastasis in breast cancer
por: Thakur, Ravi, et al.
Publicado: (2015) -
Proteasome inhibitors as experimental therapeutics of autoimmune diseases
por: Verbrugge, Sue Ellen, et al.
Publicado: (2015) -
Therapeutic Strategies against Epstein-Barr Virus-Associated Cancers Using Proteasome Inhibitors
por: Hui, Kwai Fung, et al.
Publicado: (2017)